Back to trial details

Intake questionnaire

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Applying to The University of Chicago Medical Center · Chicago, Illinois

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you between 18 and 74 years old?
2. Have you been diagnosed with Systemic Lupus Erythematosus (With and Without Nephritis)?
3. Are you able to travel to Chicago for study visits?